Wednesday, October 5, 2011

SV Life Sciences Names New Venture Partner

SV Life Sciences, the venture capital investment firm with offices in Boston, San Francisco, and London, said Wednesday afternoon that it ha named Dr. Heiner Dreismann as a new Ventuer Partners. Dr. Dreismann has previously served at Roche Group, where he was President and CEO of Roche Molecular Systems, Head of Global Business Development at Roche Diagnostics and Member of Roche's Global Diagnostic Executive Committee. SV Life Sciences has approximately $2 billion of capital under management.